Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-15 · accession 0002064832-26-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-02-18 | 2026-02-15 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | F - Tax | $3.73 | -271.4K | 3.49M | -7% | -$1.01M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-02-15 | F | D | 85,605 | $3.73 | 3,243,917 | D | — | — | |
| 2 | Common | Class A Common Stock | 2026-02-15 | F | D | 82,815 | $3.73 | 3,329,522 | D | — | — | |
| 3 | Common | Class A Common Stock | 2026-02-15 | F | D | 78,646 | $3.73 | 3,412,337 | D | — | — | |
| 4 | Common | Class A Common Stock | 2026-02-15 | F | D | 24,340 | $3.73 | 3,490,983 | D | — | — |